share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 16 16:21
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at an aggregate market value of $191,658.73, were originally acquired on 04/20/2021 through a Pre IPO Option Exercise from the issuer. The acquisition was made with cash payment on the same date. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold, amounting to gross proceeds of $1,562,683.24. The notice of the planned sale was filed on the same date as the intended sale, with the plan for this transaction having been adopted on 03/01/2024.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at an aggregate market value of $191,658.73, were originally acquired on 04/20/2021 through a Pre IPO Option Exercise from the issuer. The acquisition was made with cash payment on the same date. This upcoming sale follows a series of transactions over the past three months where a total of 150,000 shares were sold, amounting to gross proceeds of $1,562,683.24. The notice of the planned sale was filed on the same date as the intended sale, with the plan for this transaction having been adopted on 03/01/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more